Search

Search Constraints

You searched for: Author/Creator Baselga, J

Search Results

2. 218PAutoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial. (23rd October 2018)

4. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. (3rd May 2018)

8. Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial. (26th April 2018)

9. Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial. (9th January 2019)

10. Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors. (9th January 2019)